Nontuberculous Mycobacteria Lung Disease: Management Strategies for Advanced Practice Providers

Access Activity

Overview / Abstract:

Target Audience
The intended audience for this educational initiative is nurse practitioners and physician assistants who manage patients with NTM-LD.

Program Overview
Nontuberculous mycobacterium lung disease (NTM-LD) is associated with significant morbidity and mortality with 5-year survival rates similar to that of patients with lung cancer. The incidence and prevalence of has risen dramatically in recent decades, straining the management capacity of the limited number of pulmonologist and infectious disease physicians. Thus, the role of advanced practice providers (APP), such as nurse practitioners and physician assistants, will become even more important as they take on more responsibilities in diagnosing and managing patients with NTM-LD. Based on recent conversations with NTMphysicians and APPs, as well as practice pattern studies of pulmonologists, there are multiple gaps in knowledge, skills, and attitudes regarding the diagnosis and management of NTM-LD.

Nontuberculous Mycobacteria Lung Disease: Management Strategies for Advanced Practice Providers will address the gaps in NTM-LD care by reviewing current evidence-based criteria for diagnosis and recommendations for treatment. Content will be developed by expert physicians and APPs who manage patients with NTM-LD daily and understand the barriers and issues that APPs confront in the complex nature of NTMdiagnosis and treatment.

Click here to view the Patient Resources provided by CHESTFoundation

Agenda
Welcome and Introduction
Advanced Practice Provider Roles in the Diagnostic Process for NTM-LD
Advanced Practice Provider Roles in Treatment Strategies for NTM-LD
Q & A Session and Activity Roundup
Learning Objectives
At the conclusion of an activity, participants should be able to:

Recognize patient risk factors for NTMlung disease
Accurately interpret testing results required for diagnosing NTM-LD
Communicate effectively with patients regarding the diagnosis of NTM-LD
Implement evidence-based strategies for managing and monitoring side effects of NTM-LD therapies
Educate patients undergoing NTMtreatment about selected treatments, related side effects, monitoring strategies, and treatment adherence

Expiration

Dec 15, 2022

Discipline(s)

Physician CME

Format

Online

Credits / Hours

1.0

Accreditation

ACCME, AANP, AAPA

Presenters / Authors / Faculty

Doreen Addrizzo-Harris, MD
Jeremy Amayo, MMSc, PA-C
Charles L. Daley, MD
Jennifer Faber-Gerling, RN, MS, CNS, ANP-BC

Sponsors / Supporters / Grant Providers

Insmed

Keywords / Search Terms

Relias LLC Relias, Free CME, NTM Free CE CME

Access Activity

CORE Higher Education Group, CESearchEngine.com, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the CESearchEngine.com website or within our mobile apps.CORE Higher Education Group, CESearchEngine.com, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or within our mobile apps. For complete details, please read the CESearchEngine.com Terms of Service. Site Map